Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis von Breddin, Hans K., Kadziola, Zbigniew, Scully, Mike, Nakov, Roumen, Misselwitz, Frank, Kakkar, Vijay V.

Volltext

Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis von Kakkar, Vijay V., Hoppenstead, Debra A., Fareed, Jawed, Kadziola, Zbigniew, Scully, Mike, Nakov, Roumen, Breddin, Hans K.

Volltext

Antiplatelet and Anticoagulant Effects of “HN-11 500,” a Selective Thromboxane Receptor Antagonist von Schenk, Joachim F, Radziwon, Piotr, Fellier, Harald, Breddin, Hans K

Volltext

The Effects of Polysulfonate Derivative (GL 2021) on Coagulation in Vitro and Thrombosis in Vivo von Radziwon, Piotr, Schenk, Joachim, Boczkowska-Radziwon, Barbara, Wojtukiewicz, Marek Z, Giedrojć, Jan, Kłoczko, Janusz, Breddin, Hans K

Volltext

Platelet-Induced Thrombin Generation Time II (PITT II) A Modified Global Coagulation Test to Monitor Prophylactic Anticoagulation with Vitamin K Antagonists? von Radziwon, Piotr, Boczkowska-Radziwon, Barbara, Schenk, Joachim F, Wojtukiewicz, Marek Z, Kłoczko, Janusz, Giedrojć, Jan, Breddin, Hans K

Volltext

Effects of Aprosulate, a Novel Synthetic Glycosaminoglycan, on Coagulation and Platelet Function Parameters: A Prospective, Randomized Phase I Study von Schenk, Joachim F., Radziwon, Piotr, Mörsdorf, Stefan, Eckenberger, Peter, Breddin, Hans K.

Volltext

Low molecular weight heparins in the prevention of deep-vein thrombosis in general surgery von BREDDIN, H. K

Volltext

Coronary heart disease, unstable angina, PTCA: New indications for low molecular weight heparins? von Breddin, Hans K.

Volltext

Platelet activation and its role in thrombin generation in platelet-induced thrombin generation time von Radziwon, Piotr, Boczkowska-Radziwon, Barbara, Schenk, Joachim F, Wojtukiewicz, Marek Z, Kłoczko, Janusz, Giedrojć, Jan, Breddin, Hans K

Volltext

Preclinical biochemistry and pharmacology of low molecular weight heparins in vivo-studies of venous and arterial thrombosis von KAISER, B, KIRCHMAIER, C. M, BREDDIN, H. K, KAIDING FU, FAREED, J

Volltext

Clinical management of thrombotic and cardiovascular disorders with thrombin inhibitors: the role of argatroban von BREDDIN, Hans K, WALENGA, Jeanine M

Volltext

Can platelet aggregometry be standardized? von Breddin, H. K.

Volltext

Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin von Lindhoff‐Last, Edelgard, Nakov, Roumen, Misselwitz, Frank, Breddin, Hans‐Klaus, Bauersachs, Rupert

Volltext

Effects of a Low-Molecular-Weight Heparin on Thrombus Regression and Recurrent Thromboembolism in Patients with Deep-Vein Thrombosis von Breddin, Hans Klaus, Hach-Wunderle, Viola, Nakov, Roumen, Kakkar, Vijay V

Volltext

Aspirin and platelet function von Breddin, H. K.

Volltext

Ex vivo-in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A von Klinkhardt, Ute, Kirchmaier, Carl M., Westrup, Dagmar, Graff, Jochen, Mahnel, Rene, Breddin, Hans Klaus, Harder, Sebastian

Volltext

Reviparin sodium - a new low molecular weight heparin von Breddin, Hans Klaus

Volltext

Pharmacokinetics and pharmacodynamic effects of a new antibody glycoprotein IIb/IIIa inhibitor (YM337) in healthy subjects von HARDER, S, KIRCHMAIER, C. M, KRZYWANEK, H. J, WESTRUP, D, BAE, J.-W, BREDDIN, H. K

Volltext

Prophylaxis and Treatment of Deep-Vein Thrombosis von Breddin, Hans Klaus

Volltext

Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia von Breddin, Hans Klaus

Volltext